The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: clozapine     Quarter: 2016Q3

Total Records: 492     Number of Pages: 25

DRUGNAME PT EventCount
CLOZAPINE. Hallucinations, mixed 2
CLOZAPINE. Hepatic steatosis 2
CLOZAPINE. Homicide 2
CLOZAPINE. Hyperlipidaemia 2
CLOZAPINE. Hypertension 2
CLOZAPINE. Infection 2
CLOZAPINE. Inflammation 2
CLOZAPINE. Irritability 2
CLOZAPINE. Lipase increased 2
CLOZAPINE. Lupus-like syndrome 2
CLOZAPINE. Macrocephaly 2
CLOZAPINE. Motor dysfunction 2
CLOZAPINE. Myalgia 2
CLOZAPINE. Myocardial infarction 2
CLOZAPINE. Neurogenic bladder 2
CLOZAPINE. Neurological decompensation 2
CLOZAPINE. Neutrophil count decreased 2
CLOZAPINE. Non-Hodgkin's lymphoma 2
CLOZAPINE. Obsessive-compulsive disorder 2
CLOZAPINE. Oculogyric crisis 2

Total Records: 492     Number of Pages: 25